Wealth Enhancement Advisory Services’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Buy
36,469
+12,164
+50% +$96.1K ﹤0.01% 3184
2026
Q1
$171K Sell
24,305
-3,235
-12% -$23.9K ﹤0.01% 3190
2025
Q4
$310K Buy
27,540
+1,707
+7% +$18.9K ﹤0.01% 2895
2025
Q3
$286K Sell
25,833
-3,281
-11% -$39.7K ﹤0.01% 2840
2025
Q2
$338K Buy
29,114
+1,478
+5% +$16.3K ﹤0.01% 2550
2025
Q1
$170K Sell
27,636
-3,409
-11% -$35.3K ﹤0.01% 2663
2024
Q4
$251K Sell
31,045
-21,139
-41% -$211K ﹤0.01% 2517
2024
Q3
$422K Buy
52,184
+4,935
+10% +$26.7K ﹤0.01% 1939
2024
Q2
$205K Buy
47,249
+3,064
+7% +$15.6K ﹤0.01% 2283
2024
Q1
$187K Buy
44,185
+1,157
+3% +$4.01K ﹤0.01% 2215
2023
Q4
$162K Buy
43,028
+1,955
+5% +$6.73K ﹤0.01% 2120
2023
Q3
$152K Buy
+41,073
New +$163K ﹤0.01% 2045

Other funds holding CRMD